Notice: This company has been marked as potentially delisted and may not be actively trading. Cambrex (CBM) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator ManufacturingDecember 5, 2024 | finance.yahoo.comSemi-Solid Dosage CDMO Market Report 2024-2030: The Lubrizol Corporation, Cambrex Corporation, and Contract Pharmaceuticals Dominate the Competitive LandscapeNovember 13, 2024 | globenewswire.comCambrex Opens New Stability Storage Facility in Durham, North CarolinaOctober 17, 2024 | finance.yahoo.comCambrex Announces New Liquid-Phase Peptide Synthesis Manufacturing TechnologySeptember 19, 2024 | finance.yahoo.comFire, gas leak at Cambrex manufacturing facility, Triad officials sayJuly 31, 2024 | msn.comOne Equity Partners Invests in Italian Agricultural Tractor Attachment Manufacturer CBMMarch 27, 2024 | tmcnet.comChina CBM Group Co Ltd 08270March 19, 2024 | morningstar.comCambrex Announces Sale of Drug Product Business UnitNovember 2, 2023 | finance.yahoo.comCBM_old Historical DataOctober 29, 2023 | investing.comSnapdragon Chemistry, a Cambrex Company, Recognized with CPhI Pharma Award for API DevelopmentOctober 24, 2023 | finance.yahoo.comSK pharmteco to showcase its extensive APIs and CGT capabilities in CPHI 2023October 18, 2023 | stockhouse.comSK pharmteco to Expand Capabilities with Acquisition of Controlling Interest in Center for Breakthrough MedicinesSeptember 21, 2023 | businesswire.comCleantech Building Materials: Result of General MeetingSeptember 7, 2023 | finance.yahoo.comDIVERGENT Energy Services Announces the Release of 2023 Second Quarter ResultsAugust 29, 2023 | markets.businessinsider.comCleantech Building Materials: Notice of General MeetingAugust 14, 2023 | finance.yahoo.comCambrex Celebrates Grand Opening of New Q1 Scientific Facility in Belgium and Secures First Stability Storage Commercial AgreementMay 31, 2023 | markets.businessinsider.comCollective Mining Drills 162.20 Metres at 3.90 g/t Gold Equivalent From Surface at the...May 30, 2023 | juniorminingnetwork.comCambrex fait l'acquisition de Snapdragon Chemistry, un leader dans les services de développement d'IPA à flux continuJanuary 18, 2023 | prnewswire.comRepair works at LRT, MRT, Monorail stations to be completed by FebruaryDecember 24, 2022 | msn.comVitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2028 - ResearchAndMarkets.com - Business WireOctober 14, 2022 | businesswire.comWith 5.0% CAGR, Small Molecule API Market Size Worth US$ 300.2 Billion by 2030 | Research for Developing - BenzingaOctober 9, 2022 | benzinga.comCambrex Announces Stability Storage Expansions in Ireland and BelgiumOctober 5, 2022 | markets.businessinsider.comCambrex Announces Stability Storage Expansions in Ireland and Belgium - PR NewswireOctober 4, 2022 | prnewswire.comMedicx Health Appoints Theresa Greco as President and Stacey Levas as Senior Vice President of Marketing - StreetInsider.comSeptember 28, 2022 | streetinsider.comInvestigational New Drug CDMO Market worth $7.47 billion by 2030 - Exclusive Report by InsightAce Analytic - PR NewswireSeptember 27, 2022 | prnewswire.comBlockchain Moon Acquisition Corp. appoints John P. Hopkins and Carl J. Johnson as new Independent Directors - Yahoo FinanceSeptember 20, 2022 | finance.yahoo.comONGC wants govt to scrap windfall tax, USD 10 gas priceSeptember 19, 2022 | msn.comONGC wants government to scrap windfall tax on domestically produced crude oilSeptember 19, 2022 | msn.comKimball Electronics, Inc. Announces Appointment of Additional Director - Business WireSeptember 16, 2022 | businesswire.comCambrex finishes first phase of expansion - Yahoo NewsSeptember 2, 2022 | news.yahoo.comCambrex Completes First Phase of $30 Million Capacity Expansion Project in High Point, North Carolina - PR NewswireSeptember 1, 2022 | prnewswire.comGlobal Small-Molecule APIs Market to Reach $38.54 Billion by 2027 - PR NewswireAugust 19, 2022 | prnewswire.comGlobal Small-Molecule APIs Market Report 2022: Increasing Growth of the Pharmaceutical Industry in Developing Nations Presents Lucrative Opportunities - Yahoo FinanceAugust 17, 2022 | finance.yahoo.comGlobal Small-Molecule APIs Market Report 2022: Rising Volume of Patients Suffering from Cancer, Cardiovascular, and Infectious Diseases Driving Growth - ResearchAndMarkets.com - Business WireAugust 17, 2022 | businesswire.comGlobal Small-Molecule APIs Market Report 2022: Increasing Growth of the Pharmaceutical Industry in Developing Nations Presents Lucrative Opportunities - GlobeNewswireAugust 17, 2022 | globenewswire.comBiopharmaceutical Contract Manufacturing to Reach Over $25 Billion by 2027. Contract manufacturing of live-attenuated Vaccines gaining popularity – Arizton - GlobeNewswireAugust 11, 2022 | globenewswire.comU.S. Small-Molecule APIs Market to Reach $7.84 Billion by 2027 - BenzingaAugust 3, 2022 | benzinga.comThe Worldwide Pharmaceutical Contract Manufacturing Industry is Projected to Reach $157.6 Billion by 2027 - BenzingaJuly 28, 2022 | benzinga.comPharmaceutical Intermediates Market is Expected to Grow Significantly in the Next Few Years, Says Future Market Insights, Inc. - BenzingaJuly 13, 2022 | benzinga.comInsights on the Pharmaceutical Contract Development & Manufacturing Global Market to 2029 - Growing Demand for Cell Therapies, Gene Therapies, and Personalized Medicines - PR NewswireJune 30, 2022 | prnewswire.comGlobal Pharmaceutical Contract Development & Manufacturing Market to 2029 - Featuring Cambrex, Samsung Biologics, Aenova and Wuxi Biologics Among Others - Yahoo FinanceJune 30, 2022 | finance.yahoo.comGlobal Pharmaceutical Contract Development & Manufacturing Market to 2029 - Featuring Cambrex, Samsung Bi - BenzingaJune 30, 2022 | benzinga.comThe Worldwide Pharmaceutical Contract Development & Manufacturing Industry is Expected to Reach $226 Billion by 2029 - ResearchAndMarkets.com - Business WireJune 29, 2022 | businesswire.comCleantech Building Materials: Financing Partner appointed to further Increase China Accoya Production CapacityJune 20, 2022 | finanznachrichten.dePharmaceutical Contract Development and Manufacturing Market Worth $226.35 Billion by 2029 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research® - Yahoo FinanceJune 17, 2022 | finance.yahoo.comPharmaceutical Contract Development and Manufacturing Market Worth $226.35 Billion by 2029 - Market Size, Share, Forecasts, & Trends Analysis Report with COVID-19 Impact by Meticulous Research® - PR NewswireJune 17, 2022 | prnewswire.comCambrex Acquires Leading EU Stability Storage Company Q1 Scientific USA - English - USA - English - PR NewswireJune 1, 2022 | prnewswire.comReinventing the Carolina Core economy - Triad Business Journal - The Business JournalsApril 29, 2022 | bizjournals.comGlobal Biologics Contract Manufacturing Market to 2031 - Industry Analysis, Size, Share, Growth, Trends and Forecasts - ResearchAndMarkets.com - Business WireApril 13, 2022 | businesswire.comENTELLIGENCE EARNS 2022 GREAT PLACE TO WORK CERTIFICATION™ - Yahoo FinanceApril 13, 2022 | finance.yahoo.com Get Cambrex News Delivered to You Automatically Sign up to receive the latest news and ratings for CBM and its competitors with MarketBeat's FREE daily newsletter. Email Address CBM Media Mentions By Week CBM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CBM News Sentiment▼0.000.64▲Average Medical News Sentiment CBM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CBM Articles This Week▼00▲CBM Articles Average Week Get Cambrex News Delivered to You Automatically Sign up to receive the latest news and ratings for CBM and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Pacific Biosciences of California News Today Harvard Bioscience News Today Thermo Fisher Scientific News Today Agilent Technologies News Today Mettler-Toledo International News Today Waters News Today Illumina News Today Bio-Techne News Today Bio-Rad Laboratories News Today Bruker News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CBM) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredTrump currency shock imminentTrump's Quiet $1.9 Trillion Move Against the Fed A small army of Americans, with Trump's support, has launc...Stansberry Research | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cambrex Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cambrex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.